Announcement of TTY Biopharm's unaudited income information in March 2021
2021.4.14
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/04/14 | Time of announcement | 16:37:23 |
| Subject | Announcement of TTY Biopharm's unaudited income information in March 2021 | ||||
| Date of events | 2021/04/14 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/04/14 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $322,718 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $64,286 thousands, and a consolidated income before tax of $89,463 thousands in March 2021; net income attributed to stockholders of the company was $72,629 thousands; EPS is $0.29. Year-to-date consolidated net sales was $964,056 thousands (in NT dollars; unaudited), a consolidated operating profit was $219,158 thousands and consolidated income before tax was $254,325 thousands until March 2021; year-to-date net income attributed to stockholders of the company was $204,425 thousands; EPS is $0.82. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||